Immunic Inc
(NAS:IMUX)
$
1.405
-0.045 (-3.1%)
Market Cap: 126.56 Mil
Enterprise Value: 47.82 Mil
PE Ratio: 0
PB Ratio: 2.04
GF Score: 43/100 Immunic Inc (IMUX) Transcripts
- Q3 2023 Immunic Inc Earnings Call TranscriptNov 14, 2023$0.9902 (+2.16%)Earnings
- Immunic Inc To Discuss Interim Data Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive MS Call TranscriptOct 10, 2023
- Q2 2023 Immunic Inc Earnings Call TranscriptAug 03, 2023$2.13 (-1.39%)Earnings
- Immunic Inc To Host Key Opinion Leaders TranscriptJul 20, 2023
- Q1 2023 Immunic Inc Earnings Call TranscriptMay 11, 2023$1.82 (+1.68%)Earnings
- Immunic Inc To Discuss IMU-856 Clinical Phase 1b Results in Celiac Disease Call TranscriptMay 04, 2023
- Immunic Inc To Discuss Phase 2b CALDOSE-1 Maintenance Phase Data Call TranscriptApr 05, 2023
- Q4 2022 Immunic Inc Earnings Call TranscriptFeb 23, 2023$1.97 (+4.23%)Earnings
- Immunic Inc Celiac Disease R&D Webcast TranscriptFeb 09, 2023
- Immunic Inc Corporate Call TranscriptNov 17, 2022
- Q3 2022 Immunic Inc Earnings Call TranscriptNov 03, 2022$1.58 (-7.60%)Earnings
- Immunic Inc Webinar: IMU-856 Phase 1 SAD/MAD Data in Healthy Human Subjects TranscriptSep 20, 2022
- Q2 2022 Immunic Inc Earnings Call TranscriptAug 04, 2022$4.79 (+23.14%)Earnings
- Immunic Inc Corporate Update TranscriptJun 02, 2022
- Q1 2022 Immunic Inc Earnings Call TranscriptMay 10, 2022$5.5 (+5.36%)Earnings
- Q4 2021 Immunic Inc Earnings Call TranscriptFeb 24, 2022$10.72 (-9.15%)Earnings
- Q3 2021 Immunic Inc Earnings Call TranscriptNov 04, 2021$10.25 (+2.60%)Earnings
- Immunic Inc Discuss Overall MS Development Strategy - Corporate Call TranscriptJul 01, 2021
- Q2 2020 Immunic Inc Earnings Call TranscriptAug 03, 2020Earnings
- 1